💬In plain words
What the trial is, and whether it could suit you
The goal of this observational study is to characterise changes in gene expression in endothelial cells in patients with either sepsis or post major abdominal surgery.
The main question we plan to answer is: 'What molecular pathways are differentially expressed during inflammatory pathologies?'
Sign in to get the eligibility rules as simple questions to take to your doctor.
📋 Eligibility rules (as published)
Inclusion Criteria:
Healthy volunteer
* Adult ≥ 18 years
* Able and willing to give consent
Surgical patients
* Adult ≥ 18 years
* Patients admitted to RSFT for planned major surgery
Critically ill patients
* Adult ≥ 18 years
* Emergency admission to ICU at RSFT
* Meets the sepsis 3.0 definition
Exclusion Criteria:
Healthy volunteer
* Not currently a patient within the hospital
* Absence of inflammatory diseases and disorders including but not limited to arthritis, peripheral artery disease, vasculitis, diabetes, cardiovascular disease and CKD.
* Not on immunomodulatory medications, such as corticosteroids
* History of recent major trauma within the last 2 months (e.g., surgery or injury requiring hospitalisation)
Surgical patients
* Patients with restricted liberty, prisoners or under legal protection
* Anticipated prohibitively difficult venous cannulation
* Presenting with inflammatory diseases and disorders including but not limited to arthritis, peripheral artery disease, vasculitis, sepsis, diabetes with end organ damage, cardiovascular disease and CKD
* Currently prescribed immunomodulatory medication or immunocompromised
* Received chemotherapy within 2 weeks of predicted sampling
* Receiving vasopressor support prior to surgery
* History of recent major trauma within the last 2 months (e.g., surgery or injury requiring hospitalisation)
Critically ill patients
* Patients with restricted liberty, prisoners or under legal protection• Anticipated prohibitively difficult venous cannulation
* Presenting with inflammatory diseases and disorders including but not limited to arthritis, peripheral artery disease, vasculitis, diabetes with end organ damage, cardiovascular disease and CKD.
* Currently prescribed immunomodulatory medication or immunocompromised
* Received chemotherapy within 2 weeks of predicted sampling.
* History of recent major trauma within the last 2 months (e.g., surgery or injury requiring hospitalisation)